世界の13価肺炎球菌多糖結合型ワクチン（PCV13）市場2021-2026：血清型6B、7F血清型、血清型9V、14血清型、血清型18C、血清型19A、19F血清型、23F血清型、24F血清型

◆英語タイトル：Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Market Growth 2021-2026
◆商品コード：LPI21MY9698
◆発行会社（リサーチ会社）：LP Information
◆発行日：2021年5月（※2024年版があります。お問い合わせください）
◆ページ数：130
◆レポート形式：英語 / PDF
◆納品方法：Eメール（受注後2-3営業日）
◆調査対象地域：グローバル、日本、アメリカ、ヨーロッパ、アジア、中国など
◆産業分野：医薬品
◆販売価格オプション（消費税別）

Single User（1名様閲覧用）	USD3,660 ⇒換算￥541,680	見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）	USD5,490 ⇒換算￥812,520	見積依頼/購入/質問フォーム
Corporate User（閲覧人数制限なし）	USD7,320 ⇒換算￥1,083,360	見積依頼/購入/質問フォーム

★LP Informationに受託調査の見積を依頼する

※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※本体価格が￥30,000未満のレポートにつきましては、ハンドリングチャージ￥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はLP Information社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。LP Information社の概要及び新刊レポートはこちらでご確認いただけます。

LPインフォメーション社の「13価肺炎球菌多糖結合型ワクチン（PCV13）の世界市場」調査資料は、南北アメリカ、アジア、ヨーロッパ、中東・アフリカ市場を対象にしており、種類別には、血清型6B、7F血清型、血清型9V、14血清型、血清型18C、血清型19A、19F血清型、23F血清型、24F血清型など、用途別には、生後6週間-15ヶ月乳児、15ヶ月-5歳子供などにセグメント区分してまとめました。13価肺炎球菌多糖結合型ワクチン（PCV13）のグローバル市場規模、主要地域・主要国別、種類別、用途別の市場予測、主要企業の概要・市場シェア・販売量、市場動向などの情報が掲載されています。
・13価肺炎球菌多糖結合型ワクチン（PCV13）の世界市場概要（サマリー）
・13価肺炎球菌多糖結合型ワクチン（PCV13）の企業別販売量・売上
・13価肺炎球菌多糖結合型ワクチン（PCV13）の企業別市場シェア
・13価肺炎球菌多糖結合型ワクチン（PCV13）の世界市場規模 2016年-2021年：種類別（血清型6B、7F血清型、血清型9V、14血清型、血清型18C、血清型19A、19F血清型、23F血清型、24F血清型）
・13価肺炎球菌多糖結合型ワクチン（PCV13）の世界市場規模 2016年-2021年：用途別（生後6週間-15ヶ月乳児、15ヶ月-5歳子供）
・13価肺炎球菌多糖結合型ワクチン（PCV13）の南北アメリカ市場規模（アメリカ、カナダ、メキシコなど）
・13価肺炎球菌多糖結合型ワクチン（PCV13）のアジア市場規模（日本、中国、韓国、インド、東南アジアなど）
・13価肺炎球菌多糖結合型ワクチン（PCV13）のヨーロッパ市場規模（ドイツ、フランス、イギリス、イタリア、ロシアなど）
・13価肺炎球菌多糖結合型ワクチン（PCV13）の中東・アフリカ市場（エジプト、南アフリカ、トルコ、GCC諸国など）
・13価肺炎球菌多糖結合型ワクチン（PCV13）市場の成長要因・課題・動向
・13価肺炎球菌多糖結合型ワクチン（PCV13）の世界市場予測 2021年-2026年
・13価肺炎球菌多糖結合型ワクチン（PCV13）の南北アメリカ市場予測（アメリカ、カナダ、メキシコなど）
・13価肺炎球菌多糖結合型ワクチン（PCV13）のアジア市場予測（日本、中国、韓国、インド、東南アジアなど）
・13価肺炎球菌多糖結合型ワクチン（PCV13）のヨーロッパ市場予測（ドイツ、フランス、イギリス、イタリア、ロシアなど）
・13価肺炎球菌多糖結合型ワクチン（PCV13）の中東・アフリカ市場予測（エジプト、南アフリカ、トルコ、GCC諸国など）
・13価肺炎球菌多糖結合型ワクチン（PCV13）の世界市場予測：種類別（血清型6B、7F血清型、血清型9V、14血清型、血清型18C、血清型19A、19F血清型、23F血清型、24F血清型）
・13価肺炎球菌多糖結合型ワクチン（PCV13）の世界市場予測：用途別（生後6週間-15ヶ月乳児、15ヶ月-5歳子供）
・主要企業分析

【レポートの概要】

According to this latest study, the 2021 growth of 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) will have significant change from previous year. By the most conservative estimates of global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ xx million in 2020. Over the next five years the 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2026.

This report presents a comprehensive overview, market shares, and growth opportunities of 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) market by product type, application, key manufacturers and key regions and countries.

Segmentation by type: breakdown data from 2016 to 2021, in Section 2.3; and forecast to 2026 in section 11.7.
Serotype 6B
7F Serotype
Serotype 9V
14 Serotype
Serotype 18C
Serotype 19A
19F Serotype
23F Serotype
24F Serotype

Segmentation by application: breakdown data from 2016 to 2021, in Section 2.4; and forecast to 2026 in section 11.8.
Infants from 6 Weeks to 15 Months Old
Children Aged 15 Months to 5 Years

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in Chapter 3.
Pfizer
Minhai Bio
Kexing Bio
Cansino Bio
Lanzhou Biological Preparations Institute

【レポートの目次】

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered

2 Executive Summary
2.1 World Market Overview
2.1.1 Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Consumption 2016-2026
2.1.2 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Consumption CAGR by Region
2.2 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Segment by Type
2.2.1 Serotype 6B
2.2.2 7F Serotype
2.2.3 Serotype 9V
2.2.4 14 Serotype
2.2.5 Serotype 18C
2.2.6 Serotype 19A
2.2.7 19F Serotype
2.2.8 23F Serotype
2.2.9 24F Serotype
2.2.10 Other
2.3 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales by Type
2.3.1 Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales Market Share by Type (2016-2021)
2.3.2 Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Revenue and Market Share by Type (2016-2021)
2.3.3 Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sale Price by Type (2016-2021)
2.4 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Segment by Application
2.4.1 Infants from 6 Weeks to 15 Months Old
2.4.2 Children Aged 15 Months to 5 Years
2.5 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales by Application
2.5.1 Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sale Market Share by Application (2016-2021)
2.5.2 Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Revenue and Market Share by Application (2016-2021)
2.5.3 Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sale Price by Application (2016-2021)

3 Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) by Company
3.1 Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales Market Share by Company
3.1.1 Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales by Company (2019-2021)
3.1.2 Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales Market Share by Company (2019-2021)
3.2 Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Revenue Market Share by Company
3.2.1 Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Revenue by Company (2019-2021)
3.2.2 Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Revenue Market Share by Company (2019-2021)
3.3 Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sale Price by Company
3.4 Global Manufacturers 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Product Location Distribution
3.4.2 Players 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2021)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion

4 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) by Region
4.1 Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) by Region
4.1.1 Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales by Region
4.1.2 Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Revenue by Region
4.2 Americas 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales Growth
4.3 APAC 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales Growth
4.4 Europe 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales Growth
4.5 Middle East & Africa 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales Growth

5 Americas
5.1 Americas 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales by Country
5.1.1 Americas 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales by Country (2016-2021)
5.1.2 Americas 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Revenue by Country (2016-2021)
5.2 Americas 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales by Type
5.3 Americas 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC
6.1 APAC 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales by Region
6.1.1 APAC 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales by Region (2016-2021)
6.1.2 APAC 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Revenue by Region (2016-2021)
6.2 APAC 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales by Type
6.3 APAC 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia

7 Europe
7.1 Europe 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) by Country
7.1.1 Europe 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales by Country (2016-2021)
7.1.2 Europe 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Revenue by Country (2016-2021)
7.2 Europe 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales by Type
7.3 Europe 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 Middle East & Africa
8.1 Middle East & Africa 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) by Country
8.1.1 Middle East & Africa 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales by Country (2016-2021)
8.1.2 Middle East & Africa 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Revenue by Country (2016-2021)
8.2 Middle East & Africa 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales by Type
8.3 Middle East & Africa 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Country

9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends

10 Marketing, Distributors and Customer
10.1 Sales Channel
10.1.1 Direct Channels
10.1.2 Indirect Channels
10.2 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Distributors
10.3 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Customer

11 Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Market Forecast
11.1 Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Forecast by Region
11.1.1 Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Forecast by Regions (2021-2026)
11.2.2 Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Revenue Forecast by Regions (2021-2026)
11.2 Americas Forecast by Country
11.3 APAC Forecast by Region
11.4 Europe Forecast by Country
11.5 Middle East & Africa Forecast by Country
11.6 Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Forecast by Type
11.7 Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Forecast by Application

12 Key Players Analysis
12.1 Pfizer
12.1.1 Pfizer Company Information
12.1.2 Pfizer 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Product Offered
12.1.3 Pfizer 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales, Revenue, Price and Gross Margin (2019-2021)
12.1.4 Pfizer Main Business Overview
12.1.5 Pfizer Latest Developments
12.2 Minhai Bio
12.2.1 Minhai Bio Company Information
12.2.2 Minhai Bio 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Product Offered
12.2.3 Minhai Bio 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales, Revenue, Price and Gross Margin (2019-2021)
12.2.4 Minhai Bio Main Business Overview
12.2.5 Minhai Bio Latest Developments
12.3 Kexing Bio
12.3.1 Kexing Bio Company Information
12.3.2 Kexing Bio 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Product Offered
12.3.3 Kexing Bio 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales, Revenue, Price and Gross Margin (2019-2021)
12.3.4 Kexing Bio Main Business Overview
12.3.5 Kexing Bio Latest Developments
12.4 Cansino Bio
12.4.1 Cansino Bio Company Information
12.4.2 Cansino Bio 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Product Offered
12.4.3 Cansino Bio 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales, Revenue, Price and Gross Margin (2019-2021)
12.4.4 Cansino Bio Main Business Overview
12.4.5 Cansino Bio Latest Developments
12.5 Lanzhou Biological Preparations Institute
12.5.1 Lanzhou Biological Preparations Institute Company Information
12.5.2 Lanzhou Biological Preparations Institute 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Product Offered
12.5.3 Lanzhou Biological Preparations Institute 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales, Revenue, Price and Gross Margin (2019-2021)
12.5.4 Lanzhou Biological Preparations Institute Main Business Overview
12.5.5 Lanzhou Biological Preparations Institute Latest Developments
…

13 Research Findings and Conclusion

List of Tables
Table 1. 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Consumption CAGR by Region (2020-2026) & ($ Millions)
Table 2. Major Players of Serotype 6B
Table 3. Major Players of 7F Serotype
Table 4. Major Players of Serotype 9V
Table 5. Major Players of 14 Serotype
Table 6. Major Players of Serotype 18C
Table 7. Major Players of Serotype 19A
Table 8. Major Players of 19F Serotype
Table 9. Major Players of 23F Serotype
Table 10. Major Players of 24F Serotype
Table 11. Major Players of Other
Table 12. Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales by Type (2016-2021) & (K Units)
Table 13. Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales Market Share by Type (2016-2021)
Table 14. Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Revenue by Type (2016-2021) & ($ million)
Table 15. Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Revenue Market Share by Type (2016-2021)
Table 16. Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sale Price by Type (2016-2021)
Table 17. Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales by Application (2016-2021) & (K Units)
Table 18. Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales Market Share by Application (2016-2021)
Table 19. Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Value by Application (2016-2021)
Table 20. Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Revenue Market Share by Application (2016-2021)
Table 21. Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sale Price by Application (2016-2021)
Table 22. Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales by Company (2019-2021) & (K Units)
Table 23. Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales Market Share by Company (2019-2021)
Table 24. Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Revenue by Company (2019-2021) ($ Millions)
Table 25. Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Revenue Market Share by Company (2019-2021)
Table 26. Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sale Price by Company (2019-2021)
Table 27. Key Manufacturers 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Producing Area Distribution and Sales Area
Table 28. Players 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Products Offered
Table 29. 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Concentration Ratio (CR3, CR5 and CR10) & (2019-2021)
Table 30. New Products and Potential Entrants
Table 31. Mergers & Acquisitions, Expansion
Table 32. Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales by Region (2016-2021) (K Units)
Table 33. Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales Market Share by Region (2016-2021)
Table 34. Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Revenue by Region (2016-2021) & ($ Millions)
Table 35. Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Revenue Market Share by Region (2016-2021)
Table 36. Americas 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales by Country (2016-2021) & (K Units)
Table 37. Americas 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales Market Share by Country (2016-2021)
Table 38. Americas 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Revenue by Country (2016-2021) & ($ Millions)
Table 39. Americas 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Revenue Market Share by Country (2016-2021)
Table 40. Americas 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales by Type (2016-2021) & (K Units)
Table 41. Americas 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales Market Share by Type (2016-2021)
Table 42. Americas 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales by Application (2016-2021) & (K Units)
Table 43. Americas 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales Market Share by Application (2016-2021)
Table 44. APAC 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales by Region (2016-2021) & (K Units)
Table 45. APAC 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales Market Share by Region (2016-2021)
Table 46. APAC 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Revenue by Region (2016-2021) & ($ Millions)
Table 47. APAC 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Revenue Market Share by Region (2016-2021)
Table 48. APAC 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales by Type (2016-2021) & (K Units)
Table 49. APAC 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales Market Share by Type (2016-2021)
Table 50. APAC 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales by Application (2016-2021) & (K Units)
Table 51. APAC 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales Market Share by Application (2016-2021)
Table 52. Europe 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales by Country (2016-2021) & (K Units)
Table 53. Europe 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales Market Share by Country (2016-2021)
Table 54. Europe 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Revenue by Country (2016-2021) & ($ Millions)
Table 55. Europe 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Revenue Market Share by Country (2016-2021)
Table 56. Europe 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales by Type (2016-2021) & (K Units)
Table 57. Europe 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales Market Share by Type (2016-2021)
Table 58. Europe 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales by Application (2016-2021) & (K Units)
Table 59. Europe 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales Market Share by Application (2016-2021)
Table 60. Middle East & Africa 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales by Country (2016-2021) & (K Units)
Table 61. Middle East & Africa 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales Market Share by Country (2016-2021)
Table 62. Middle East & Africa 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Revenue by Country (2016-2021) & ($ Millions)
Table 63. Middle East & Africa 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Revenue Market Share by Country (2016-2021)
Table 64. Middle East & Africa 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales by Type (2016-2021) & (K Units)
Table 65. Middle East & Africa 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales Market Share by Type (2016-2021)
Table 66. Middle East & Africa 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales by Application (2016-2021) & (K Units)
Table 67. Middle East & Africa 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales Market Share by Application (2016-2021)
Table 68. Key and Potential Regions of 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13)
Table 69. Key Application and Potential Industries of 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13)
Table 70. Key Challenges of 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13)
Table 71. Key Trends of 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13)
Table 72. 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Distributors List
Table 73. 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Customer List
Table 74. Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales Forecast by Region (2021-2026) & (K Units)
Table 75. Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Consumption Market Forecast by Region
Table 76. Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Revenue Forecast by Region (2021-2026) & ($ millions)
Table 77. Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Revenue Market Share Forecast by Region (2021-2026)
Table 78. Americas 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales Forecast by Country (2021-2026) & (K Units)
Table 79. Americas 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Revenue Forecast by Country (2021-2026) & ($ millions)
Table 80. APAC 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales Forecast by Region (2021-2026) & (K Units)
Table 81. APAC 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Revenue Forecast by Region (2021-2026) & ($ millions)
Table 82. Europe 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales Forecast by Country (2021-2026) & (K Units)
Table 83. Europe 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Revenue Forecast by Country (2021-2026) & ($ millions)
Table 84. Middle East & Africa 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales Forecast by Country (2021-2026) & (K Units)
Table 85. Middle East & Africa 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Revenue Forecast by Country (2021-2026) & ($ millions)
Table 86. Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales Forecast by Type (2021-2026) & (K Units)
Table 87. Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales Market Share Forecast by Type (2021-2026)
Table 88. Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Revenue Forecast by Type (2021-2026) & ($ Millions)
Table 89. Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Revenue Market Share Forecast by Type (2021-2026)
Table 90. Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales Forecast by Application (2021-2026) & (K Units)
Table 91. Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales Market Share Forecast by Application (2021-2026)
Table 92. Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Revenue Forecast by Application (2021-2026) & ($ Millions)
Table 93. Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Revenue Market Share Forecast by Application (2021-2026)
Table 94. Pfizer Basic Information, 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Manufacturing Base, Sales Area and Its Competitors
Table 95. Pfizer 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Product Offered
Table 96. Pfizer 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 97. Pfizer Main Business
Table 98. Pfizer Latest Developments
Table 99. Minhai Bio Basic Information, 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Manufacturing Base, Sales Area and Its Competitors
Table 100. Minhai Bio 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Product Offered
Table 101. Minhai Bio 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 102. Minhai Bio Main Business
Table 103. Minhai Bio Latest Developments
Table 104. Kexing Bio Basic Information, 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Manufacturing Base, Sales Area and Its Competitors
Table 105. Kexing Bio 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Product Offered
Table 106. Kexing Bio 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 107. Kexing Bio Main Business
Table 108. Kexing Bio Latest Developments
Table 109. Cansino Bio Basic Information, 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Manufacturing Base, Sales Area and Its Competitors
Table 110. Cansino Bio 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Product Offered
Table 111. Cansino Bio 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 112. Cansino Bio Main Business
Table 113. Cansino Bio Latest Developments
Table 114. Lanzhou Biological Preparations Institute Basic Information, 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Manufacturing Base, Sales Area and Its Competitors
Table 115. Lanzhou Biological Preparations Institute 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Product Offered
Table 116. Lanzhou Biological Preparations Institute 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 117. Lanzhou Biological Preparations Institute Main Business
Table 118. Lanzhou Biological Preparations Institute Latest Developments
List of Figures
Figure 1. Picture of 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13)
Figure 2. 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales Growth Rate 2016-2026 (K Units)
Figure 7. Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Revenue Growth Rate 2016-2026 ($ Millions)
Figure 8. 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales by Region (2021 & 2026) & ($ millions)
Figure 9. Product Picture of Serotype 6B
Figure 10. Product Picture of 7F Serotype
Figure 11. Product Picture of Serotype 9V
Figure 12. Product Picture of 14 Serotype
Figure 13. Product Picture of Serotype 18C
Figure 14. Product Picture of Serotype 19A
Figure 15. Product Picture of 19F Serotype
Figure 16. Product Picture of 23F Serotype
Figure 17. Product Picture of 24F Serotype
Figure 18. Product Picture of Other
Figure 19. Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales Market Share by Type in 2020
Figure 20. Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Revenue Market Share by Type (2016-2021)
Figure 21. 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Consumed in Infants from 6 Weeks to 15 Months Old
Figure 22. Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Market: Infants from 6 Weeks to 15 Months Old (2016-2021) & (K Units)
Figure 23. 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Consumed in Children Aged 15 Months to 5 Years
Figure 24. Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Market: Children Aged 15 Months to 5 Years (2016-2021) & (K Units)
Figure 25. Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales Market Share by Application (2016-2021)
Figure 26. Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Revenue Market Share by Application in 2020
Figure 27. 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Revenue Market by Company in 2020 ($ Million)
Figure 28. Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Revenue Market Share by Company in 2020
Figure 29. Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales Market Share by Regions (2016-2021)
Figure 30. Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Revenue Market Share by Region in 2020
Figure 31. Americas 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales 2016-2021 (K Units)
Figure 32. Americas 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Revenue 2016-2021 ($ Millions)
Figure 33. APAC 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales 2016-2021 (K Units)
Figure 34. APAC 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Revenue 2016-2021 ($ Millions)
Figure 35. Europe 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales 2016-2021 (K Units)
Figure 36. Europe 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Revenue 2016-2021 ($ Millions)
Figure 37. Middle East & Africa 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales 2016-2021 (K Units)
Figure 38. Middle East & Africa 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Revenue 2016-2021 ($ Millions)
Figure 39. Americas 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales Market Share by Country in 2020
Figure 40. Americas 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Revenue Market Share by Country in 2020
Figure 41. Americas 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales Market Share by Type in 2020
Figure 42. Americas 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales Market Share by Application in 2020
Figure 43. United States 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Revenue Growth 2016-2021 ($ Millions)
Figure 44. Canada 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Revenue Growth 2016-2021 ($ Millions)
Figure 45. Mexico 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Revenue Growth 2016-2021 ($ Millions)
Figure 46. Brazil 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Revenue Growth 2016-2021 ($ Millions)
Figure 47. APAC 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales Market Share by Region in 2020
Figure 48. APAC 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Revenue Market Share by Regions in 2020
Figure 49. APAC 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales Market Share by Type in 2020
Figure 50. APAC 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales Market Share by Application in 2020
Figure 51. China 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Revenue Growth 2016-2021 ($ Millions)
Figure 52. Japan 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Revenue Growth 2016-2021 ($ Millions)
Figure 53. Korea 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Revenue Growth 2016-2021 ($ Millions)
Figure 54. Southeast Asia 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Revenue Growth 2016-2021 ($ Millions)
Figure 55. India 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Revenue Growth 2016-2021 ($ Millions)
Figure 56. Australia 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Revenue Growth 2016-2021 ($ Millions)
Figure 57. Europe 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales Market Share by Country in 2020
Figure 58. Europe 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Revenue Market Share by Country in 2020
Figure 59. Europe 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales Market Share by Type in 2020
Figure 60. Europe 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales Market Share by Application in 2020
Figure 61. Germany 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Revenue Growth 2016-2021 ($ Millions)
Figure 62. France 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Revenue Growth 2016-2021 ($ Millions)
Figure 63. UK 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Revenue Growth 2016-2021 ($ Millions)
Figure 64. Italy 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Revenue Growth 2016-2021 ($ Millions)
Figure 65. Russia 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Revenue Growth 2016-2021 ($ Millions)
Figure 66. Middle East & Africa 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales Market Share by Country in 2020
Figure 67. Middle East & Africa 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Revenue Market Share by Country in 2020
Figure 68. Middle East & Africa 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales Market Share by Type in 2020
Figure 69. Middle East & Africa 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales Market Share by Application in 2020
Figure 70. Egypt 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Revenue Growth 2016-2021 ($ Millions)
Figure 71. South Africa 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Revenue Growth 2016-2021 ($ Millions)
Figure 72. Israel 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Revenue Growth 2016-2021 ($ Millions)
Figure 73. Turkey 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Revenue Growth 2016-2021 ($ Millions)
Figure 74. GCC Country 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Revenue Growth 2016-2021 ($ Millions)
Figure 75. Channels of Distribution
Figure 76. Distributors Profiles

【免責事項】
https://www.globalresearch.jp/disclaimer

★リサーチレポート[ 世界の13価肺炎球菌多糖結合型ワクチン（PCV13）市場2021-2026：血清型6B、7F血清型、血清型9V、14血清型、血清型18C、血清型19A、19F血清型、23F血清型、24F血清型(Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Market Growth 2021-2026)]についてメールでお問い合わせはこちらでお願いします。

グローバル市場調査/マーケットリサーチ会社：レポート販売と委託調査サービス提供 GlobalResearch.jp